Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIAA0146 Inhibitors

KIAA0146 inhibitors are a class of chemical compounds that target the protein KIAA0146, also known as ASXL3. This protein belongs to the ASXL (Additional Sex Combs-Like) family, which plays a significant role in chromatin modification and epigenetic regulation. KIAA0146 is involved in various cellular processes, including transcriptional regulation and the maintenance of gene expression profiles. By inhibiting the activity of this protein, KIAA0146 inhibitors can modulate these processes, impacting gene expression patterns and chromatin structure. The inhibition of KIAA0146 is particularly relevant for understanding how alterations in epigenetic regulators affect various signaling pathways, contributing to shifts in cellular function.

The mechanisms by which KIAA0146 inhibitors achieve their effects involve the disruption of protein-protein interactions and the alteration of post-translational modifications that are central to chromatin remodeling. These compounds are designed to interfere with specific domains of the KIAA0146 protein, such as the plant homeodomain (PHD) or other regions important for its interaction with histones and other chromatin-associated proteins. By binding to these domains, inhibitors prevent the proper assembly or function of protein complexes required for the regulation of chromatin dynamics. This, in turn, alters the chromatin landscape, potentially influencing cell differentiation, gene silencing, and other key biological processes that are tightly regulated by epigenetic mechanisms. The study of KIAA0146 inhibitors provides valuable insights into chromatin biology and the role of epigenetic factors in cellular homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, a kinase involved in autophagy, potentially impacting pathways related to KIAA0146 function.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Specific inhibitor of vacuolar type H+-ATPase, affecting autophagy, relevant to KIAA0146's role.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Inhibits autophagy by preventing lysosome acidification, potentially impacting KIAA0146-related pathways.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$65.00
$261.00
113
(3)

Inhibits autophagy through PI3K inhibition, potentially affecting KIAA0146 function.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor, known to affect autophagy and other signaling pathways, could impact KIAA0146.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Another PI3K inhibitor, potentially affecting autophagy and processes related to KIAA0146.

Spautin-1

1262888-28-7sc-507306
10 mg
$168.00
(0)

Promotes autophagy degradation, potentially affecting pathways involving KIAA0146.

hydroxychloroquine

118-42-3sc-507426
5 g
$57.00
1
(0)

Similar to Chloroquine, impacts lysosome function and autophagy, potentially affecting KIAA0146.

Lys05

1391426-24-6sc-507532
5 mg
$140.00
(0)

Dual lysosomal inhibitor, more potent than chloroquine, could affect KIAA0146-related pathways.

SAR405

1523406-39-4sc-507416
1 mg
$125.00
(0)

VPS34 inhibitor, could influence autophagy and pathways related to KIAA0146 function.